Combination of AAV-delivered tumor suppressor PTEN with anti-PD-1 loaded depot gel for enhanced antitumor immunity
Recent clinical studies have shown that mutation of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) gene in cancer cells may be associated with immunosuppressive tumor microenvironment (TME) and poor response to immune checkpoint blockade (ICB) therapy. Therefore, efficiently restorin...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383523002095 |
_version_ | 1797365568796360704 |
---|---|
author | Yongshun Zhang Lan Yang Yangsen Ou Rui Hu Guangsheng Du Shuang Luo Fuhua Wu Hairui Wang Zhiqiang Xie Yu Zhang Chunting He Cheng Ma Tao Gong Ling Zhang Zhirong Zhang Xun Sun |
author_facet | Yongshun Zhang Lan Yang Yangsen Ou Rui Hu Guangsheng Du Shuang Luo Fuhua Wu Hairui Wang Zhiqiang Xie Yu Zhang Chunting He Cheng Ma Tao Gong Ling Zhang Zhirong Zhang Xun Sun |
author_sort | Yongshun Zhang |
collection | DOAJ |
description | Recent clinical studies have shown that mutation of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) gene in cancer cells may be associated with immunosuppressive tumor microenvironment (TME) and poor response to immune checkpoint blockade (ICB) therapy. Therefore, efficiently restoring PTEN gene expression in cancer cells is critical to improving the responding rate to ICB therapy. Here, we screened an adeno-associated virus (AAV) capsid for efficient PTEN gene delivery into B16F10 tumor cells. We demonstrated that intratumorally injected AAV6-PTEN successfully restored the tumor cell PTEN gene expression and effectively inhibited tumor progression by inducing tumor cell immunogenic cell death (ICD) and increasing immune cell infiltration. Moreover, we developed an anti-PD-1 loaded phospholipid-based phase separation gel (PPSG), which formed an in situ depot and sustainably release anti-PD-1 drugs within 42 days in vivo. In order to effectively inhibit the recurrence of melanoma, we further applied a triple therapy based on AAV6-PTEN, PPSG@anti-PD-1 and CpG, and showed that this triple therapy strategy enhanced the synergistic antitumor immune effect and also induced robust immune memory, which completely rejected tumor recurrence. We anticipate that this triple therapy could be used as a new tumor combination therapy with stronger immune activation capacity and tumor inhibition efficacy. |
first_indexed | 2024-03-08T16:50:51Z |
format | Article |
id | doaj.art-395186ee00d34e7d91f24b380083ed02 |
institution | Directory Open Access Journal |
issn | 2211-3835 |
language | English |
last_indexed | 2024-03-08T16:50:51Z |
publishDate | 2024-01-01 |
publisher | Elsevier |
record_format | Article |
series | Acta Pharmaceutica Sinica B |
spelling | doaj.art-395186ee00d34e7d91f24b380083ed022024-01-05T04:24:42ZengElsevierActa Pharmaceutica Sinica B2211-38352024-01-01141350364Combination of AAV-delivered tumor suppressor PTEN with anti-PD-1 loaded depot gel for enhanced antitumor immunityYongshun Zhang0Lan Yang1Yangsen Ou2Rui Hu3Guangsheng Du4Shuang Luo5Fuhua Wu6Hairui Wang7Zhiqiang Xie8Yu Zhang9Chunting He10Cheng Ma11Tao Gong12Ling Zhang13Zhirong Zhang14Xun Sun15Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, ChinaKey Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, ChinaKey Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, ChinaKey Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, ChinaKey Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, ChinaKey Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, ChinaKey Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, ChinaKey Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, ChinaKey Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, ChinaKey Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, ChinaKey Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, ChinaKey Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, ChinaKey Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, ChinaMed-X Center for Materials, College of Polymer Science and Engineering, Sichuan University, Chengdu 610065, ChinaKey Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, ChinaKey Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China; Corresponding author.Recent clinical studies have shown that mutation of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) gene in cancer cells may be associated with immunosuppressive tumor microenvironment (TME) and poor response to immune checkpoint blockade (ICB) therapy. Therefore, efficiently restoring PTEN gene expression in cancer cells is critical to improving the responding rate to ICB therapy. Here, we screened an adeno-associated virus (AAV) capsid for efficient PTEN gene delivery into B16F10 tumor cells. We demonstrated that intratumorally injected AAV6-PTEN successfully restored the tumor cell PTEN gene expression and effectively inhibited tumor progression by inducing tumor cell immunogenic cell death (ICD) and increasing immune cell infiltration. Moreover, we developed an anti-PD-1 loaded phospholipid-based phase separation gel (PPSG), which formed an in situ depot and sustainably release anti-PD-1 drugs within 42 days in vivo. In order to effectively inhibit the recurrence of melanoma, we further applied a triple therapy based on AAV6-PTEN, PPSG@anti-PD-1 and CpG, and showed that this triple therapy strategy enhanced the synergistic antitumor immune effect and also induced robust immune memory, which completely rejected tumor recurrence. We anticipate that this triple therapy could be used as a new tumor combination therapy with stronger immune activation capacity and tumor inhibition efficacy.http://www.sciencedirect.com/science/article/pii/S2211383523002095Triple therapyAdeno-associated virusPTENPPSG@anti-PD-1CpGImmunogenic cell death |
spellingShingle | Yongshun Zhang Lan Yang Yangsen Ou Rui Hu Guangsheng Du Shuang Luo Fuhua Wu Hairui Wang Zhiqiang Xie Yu Zhang Chunting He Cheng Ma Tao Gong Ling Zhang Zhirong Zhang Xun Sun Combination of AAV-delivered tumor suppressor PTEN with anti-PD-1 loaded depot gel for enhanced antitumor immunity Acta Pharmaceutica Sinica B Triple therapy Adeno-associated virus PTEN PPSG@anti-PD-1 CpG Immunogenic cell death |
title | Combination of AAV-delivered tumor suppressor PTEN with anti-PD-1 loaded depot gel for enhanced antitumor immunity |
title_full | Combination of AAV-delivered tumor suppressor PTEN with anti-PD-1 loaded depot gel for enhanced antitumor immunity |
title_fullStr | Combination of AAV-delivered tumor suppressor PTEN with anti-PD-1 loaded depot gel for enhanced antitumor immunity |
title_full_unstemmed | Combination of AAV-delivered tumor suppressor PTEN with anti-PD-1 loaded depot gel for enhanced antitumor immunity |
title_short | Combination of AAV-delivered tumor suppressor PTEN with anti-PD-1 loaded depot gel for enhanced antitumor immunity |
title_sort | combination of aav delivered tumor suppressor pten with anti pd 1 loaded depot gel for enhanced antitumor immunity |
topic | Triple therapy Adeno-associated virus PTEN PPSG@anti-PD-1 CpG Immunogenic cell death |
url | http://www.sciencedirect.com/science/article/pii/S2211383523002095 |
work_keys_str_mv | AT yongshunzhang combinationofaavdeliveredtumorsuppressorptenwithantipd1loadeddepotgelforenhancedantitumorimmunity AT lanyang combinationofaavdeliveredtumorsuppressorptenwithantipd1loadeddepotgelforenhancedantitumorimmunity AT yangsenou combinationofaavdeliveredtumorsuppressorptenwithantipd1loadeddepotgelforenhancedantitumorimmunity AT ruihu combinationofaavdeliveredtumorsuppressorptenwithantipd1loadeddepotgelforenhancedantitumorimmunity AT guangshengdu combinationofaavdeliveredtumorsuppressorptenwithantipd1loadeddepotgelforenhancedantitumorimmunity AT shuangluo combinationofaavdeliveredtumorsuppressorptenwithantipd1loadeddepotgelforenhancedantitumorimmunity AT fuhuawu combinationofaavdeliveredtumorsuppressorptenwithantipd1loadeddepotgelforenhancedantitumorimmunity AT hairuiwang combinationofaavdeliveredtumorsuppressorptenwithantipd1loadeddepotgelforenhancedantitumorimmunity AT zhiqiangxie combinationofaavdeliveredtumorsuppressorptenwithantipd1loadeddepotgelforenhancedantitumorimmunity AT yuzhang combinationofaavdeliveredtumorsuppressorptenwithantipd1loadeddepotgelforenhancedantitumorimmunity AT chuntinghe combinationofaavdeliveredtumorsuppressorptenwithantipd1loadeddepotgelforenhancedantitumorimmunity AT chengma combinationofaavdeliveredtumorsuppressorptenwithantipd1loadeddepotgelforenhancedantitumorimmunity AT taogong combinationofaavdeliveredtumorsuppressorptenwithantipd1loadeddepotgelforenhancedantitumorimmunity AT lingzhang combinationofaavdeliveredtumorsuppressorptenwithantipd1loadeddepotgelforenhancedantitumorimmunity AT zhirongzhang combinationofaavdeliveredtumorsuppressorptenwithantipd1loadeddepotgelforenhancedantitumorimmunity AT xunsun combinationofaavdeliveredtumorsuppressorptenwithantipd1loadeddepotgelforenhancedantitumorimmunity |